TG and atherosclerosis: Although the effect of SHT, a clinical state in which the amount of circulating thyroid hormones is not optimal for that patient, on Fontan outcome was not investigated in this paper, it should be mentioned that there is a large body of evidence linking SHT in patients with cardiac disease to accelerated atherosclerosis, adverse outcome and increased mortality [3,4].